SYNDAX PHARMACEUTICALS, INC. <SNDX.O>: BOFA GLOBAL RESEARCH CUTS PRICE OBJECTIVE TO $26 FROM $29
Reuters2026/08/05 11:55By:Reuters
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
SYNDAX PHARMACEUTICALS, INC.
: BOFA GLOBAL RESEARCH CUTS PRICE OBJECTIVE TO $26 FROM $29
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Citadel Advisors discloses net short position in Valneva shares
Reuters•2026/09/10 13:45
D.E. Shaw discloses net short position in Renault shares
Reuters•2026/09/10 13:45
WorldQuant discloses net short position in Viridien shares
Reuters•2026/09/10 13:45